Lysergic acid diethylamide for depression — a randomized, double-blind, low dose-controlled phase ii trial
Autor: | Müller, F., Zaczek, H., Becker, A.M., Ley, L., Borgwardt, S., Santos de Jesus, J., Loh, N., Kohut, J., Auernig, M., Böhlke, C., Liechti, M.E. |
---|---|
Zdroj: | In Neuroscience Applied 2023 2 Supplement 2 |
Databáze: | ScienceDirect |
Externí odkaz: |